Melanie’s diverse commercial and intellectual property litigation practice encompasses patent, trademark, complex commercial, class actions, product liability, cannabis and technology disputes. Melanie excels at litigating cases in emerging fields. She was counsel in the first biologic and biosimilar drug patent cases in Canada in addition to numerous precedent-setting trials, applications and appeals. Melanie works extensively with life sciences companies on complex litigation of all types and is intimately familiar with the business of pharma and biotech. She also has broad experience in the software, tech and social media spaces, dealing with commercial, patent, trademark, copyright and licensing disputes. Melanie leverages her unique experiences to navigate a wide variety of complex litigation, adeptly devising strategic options and addressing cross-border issues. Melanie also acts on commercial and M&A transactions involving significant intellectual property assets and IP and IT licensing. She provides guidance on corporate governance with a focus on technology companies. Melanie is widely sought after for her advice on deal and litigation strategy, the evaluation and management of IP portfolios, regulatory issues and international considerations.
Melanie is consistently recognized as a leading litigator, including as one of the Top 50 Women Litigators in Canada by Benchmark Litigation, as one of the Top 250 Women in IP worldwide by Managing Intellectual Property IP Stars and in all major directories including Chambers and Lexpert. She regularly speaks on IP, business law and advocacy topics, and is an active member in numerous professional organizations. Melanie co-leads Blakes’ IP Litigation practice.